| 1 | therapies | 14,227 |
| 2 | therapeutics | 865 |
| 3 | pharmacotherapies | 342 |
| 4 | immunotherapies | 99 |
| 5 | immunotherapeutics | 16 |
| 6 | antifolates | 14 |
| 7 | theranostics | 10 |
| 8 | awcms | 7 |
| 9 | expires | 5 |
| 10 | megascores | 4 |
| 11 | arg625 | 2 |
| 12 | aspirin/dipyridamol | 2 |
| 13 | biopsy/polypectomy | 2 |
| 14 | bolaamphiphiles | 2 |
| 15 | chemotherapeuticals | 2 |
| 16 | mensuration | 2 |
| 17 | subchannels | 2 |
| 18 | therapy.there | 2 |
| 19 | treatment-algorithm | 2 |
| 20 | unfitness | 2 |
| 21 | xenohormetins | 2 |
| 22 | 4-sulfonylcrotonates | 1 |
| 23 | 6β-acylaminomorphinans | 1 |
| 24 | 7-aryl-10 | 1 |
| 25 | 8-cyano-fluoroquinolone | 1 |
| 26 | agent-sorafenib | 1 |
| 27 | agents.2 | 1 |
| 28 | albendazole/praziquantel | 1 |
| 29 | alus | 1 |
| 30 | anti-trichomonals | 1 |
| 31 | arb-derivative | 1 |
| 32 | clerodanes | 1 |
| 33 | concept/technique | 1 |
| 34 | concerns-the | 1 |
| 35 | considerations.women | 1 |
| 36 | cremophor-free | 1 |
| 37 | curtovirus | 1 |
| 38 | explanations-which | 1 |
| 39 | films/coatings | 1 |
| 40 | fluorocycline | 1 |
| 41 | h-box | 1 |
| 42 | helicobacter-gastritis | 1 |
| 43 | indolylglyoxylyldipeptides | 1 |
| 44 | indomethacin/caffeine/prochlorperazine | 1 |
| 45 | intracluster-injection | 1 |
| 46 | iuds/iuss | 1 |
| 47 | lyso-phospholipid | 1 |
| 48 | mailouts | 1 |
| 49 | metalloprotease-independent | 1 |
| 50 | microphototherapy | 1 |
| 51 | nano-biotechnology | 1 |
| 52 | nullosomy | 1 |
| 53 | p.asp82glu | 1 |
| 54 | peripheral+evidential | 1 |
| 55 | polyetherurethane | 1 |
| 56 | publications,3,4,6,7 | 1 |
| 57 | radio-sensitizers | 1 |
| 58 | radioprobes | 1 |
| 59 | rapamycin-regulated | 1 |
| 60 | reversers | 1 |
| 61 | rightwards | 1 |
| 62 | sclerotherapies | 1 |
| 63 | segment-i.e. | 1 |
| 64 | segra | 1 |
| 65 | skull-mounted | 1 |
| 66 | suffocants | 1 |
| 67 | therapies-sunitinib | 1 |
| 68 | ticlopidine-aspirin | 1 |
| 69 | twine | 1 |
| 70 | α-emitter | 1 |
| 1 | 4-sulfonylcrotonates | 1 |
| 2 | 6β-acylaminomorphinans | 1 |
| 3 | 7-aryl-10 | 1 |
| 4 | 8-cyano-fluoroquinolone | 1 |
| 5 | agent-sorafenib | 1 |
| 6 | agents.2 | 1 |
| 7 | albendazole/praziquantel | 1 |
| 8 | alus | 1 |
| 9 | anti-trichomonals | 1 |
| 10 | antifolates | 14 |
| 11 | arb-derivative | 1 |
| 12 | arg625 | 2 |
| 13 | aspirin/dipyridamol | 2 |
| 14 | awcms | 7 |
| 15 | biopsy/polypectomy | 2 |
| 16 | bolaamphiphiles | 2 |
| 17 | chemotherapeuticals | 2 |
| 18 | clerodanes | 1 |
| 19 | concept/technique | 1 |
| 20 | concerns-the | 1 |
| 21 | considerations.women | 1 |
| 22 | cremophor-free | 1 |
| 23 | curtovirus | 1 |
| 24 | expires | 5 |
| 25 | explanations-which | 1 |
| 26 | films/coatings | 1 |
| 27 | fluorocycline | 1 |
| 28 | h-box | 1 |
| 29 | helicobacter-gastritis | 1 |
| 30 | immunotherapeutics | 16 |
| 31 | immunotherapies | 99 |
| 32 | indolylglyoxylyldipeptides | 1 |
| 33 | indomethacin/caffeine/prochlorperazine | 1 |
| 34 | intracluster-injection | 1 |
| 35 | iuds/iuss | 1 |
| 36 | lyso-phospholipid | 1 |
| 37 | mailouts | 1 |
| 38 | megascores | 4 |
| 39 | mensuration | 2 |
| 40 | metalloprotease-independent | 1 |
| 41 | microphototherapy | 1 |
| 42 | nano-biotechnology | 1 |
| 43 | nullosomy | 1 |
| 44 | p.asp82glu | 1 |
| 45 | peripheral+evidential | 1 |
| 46 | pharmacotherapies | 342 |
| 47 | polyetherurethane | 1 |
| 48 | publications,3,4,6,7 | 1 |
| 49 | radio-sensitizers | 1 |
| 50 | radioprobes | 1 |
| 51 | rapamycin-regulated | 1 |
| 52 | reversers | 1 |
| 53 | rightwards | 1 |
| 54 | sclerotherapies | 1 |
| 55 | segment-i.e. | 1 |
| 56 | segra | 1 |
| 57 | skull-mounted | 1 |
| 58 | subchannels | 2 |
| 59 | suffocants | 1 |
| 60 | theranostics | 10 |
| 61 | therapeutics | 865 |
| 62 | therapies | 14,227 |
| 63 | therapies-sunitinib | 1 |
| 64 | therapy.there | 2 |
| 65 | ticlopidine-aspirin | 1 |
| 66 | treatment-algorithm | 2 |
| 67 | twine | 1 |
| 68 | unfitness | 2 |
| 69 | xenohormetins | 2 |
| 70 | α-emitter | 1 |
| 1 | segment-i.e. | 1 |
| 2 | 7-aryl-10 | 1 |
| 3 | agents.2 | 1 |
| 4 | arg625 | 2 |
| 5 | publications,3,4,6,7 | 1 |
| 6 | segra | 1 |
| 7 | agent-sorafenib | 1 |
| 8 | therapies-sunitinib | 1 |
| 9 | rapamycin-regulated | 1 |
| 10 | skull-mounted | 1 |
| 11 | lyso-phospholipid | 1 |
| 12 | cremophor-free | 1 |
| 13 | concerns-the | 1 |
| 14 | polyetherurethane | 1 |
| 15 | fluorocycline | 1 |
| 16 | twine | 1 |
| 17 | indomethacin/caffeine/prochlorperazine | 1 |
| 18 | 8-cyano-fluoroquinolone | 1 |
| 19 | therapy.there | 2 |
| 20 | concept/technique | 1 |
| 21 | arb-derivative | 1 |
| 22 | explanations-which | 1 |
| 23 | peripheral+evidential | 1 |
| 24 | albendazole/praziquantel | 1 |
| 25 | aspirin/dipyridamol | 2 |
| 26 | treatment-algorithm | 2 |
| 27 | considerations.women | 1 |
| 28 | ticlopidine-aspirin | 1 |
| 29 | mensuration | 2 |
| 30 | intracluster-injection | 1 |
| 31 | α-emitter | 1 |
| 32 | theranostics | 10 |
| 33 | therapeutics | 865 |
| 34 | immunotherapeutics | 16 |
| 35 | rightwards | 1 |
| 36 | radioprobes | 1 |
| 37 | indolylglyoxylyldipeptides | 1 |
| 38 | therapies | 14,227 |
| 39 | pharmacotherapies | 342 |
| 40 | immunotherapies | 99 |
| 41 | sclerotherapies | 1 |
| 42 | bolaamphiphiles | 2 |
| 43 | clerodanes | 1 |
| 44 | expires | 5 |
| 45 | megascores | 4 |
| 46 | antifolates | 14 |
| 47 | 4-sulfonylcrotonates | 1 |
| 48 | films/coatings | 1 |
| 49 | helicobacter-gastritis | 1 |
| 50 | chemotherapeuticals | 2 |
| 51 | anti-trichomonals | 1 |
| 52 | subchannels | 2 |
| 53 | awcms | 7 |
| 54 | 6β-acylaminomorphinans | 1 |
| 55 | xenohormetins | 2 |
| 56 | reversers | 1 |
| 57 | radio-sensitizers | 1 |
| 58 | unfitness | 2 |
| 59 | iuds/iuss | 1 |
| 60 | suffocants | 1 |
| 61 | mailouts | 1 |
| 62 | alus | 1 |
| 63 | curtovirus | 1 |
| 64 | metalloprotease-independent | 1 |
| 65 | p.asp82glu | 1 |
| 66 | h-box | 1 |
| 67 | nano-biotechnology | 1 |
| 68 | nullosomy | 1 |
| 69 | biopsy/polypectomy | 2 |
| 70 | microphototherapy | 1 |